Last reviewed · How we verify
Pre-Op Apprehension — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Chlordiazepoxide Hydrochloride | CHLORDIAZEPOXIDE | Bausch Health | Benzodiazepine | Histamine H1 receptor | 1960-01-01 | |
| Thorazine | chlorpromazine | Generic (originally Rhône-Poulenc/Sanofi) | Typical antipsychotic (first-generation, phenothiazine) | Aldehyde oxidase, Sphingomyelin phosphodiesterase, 5-hydroxytryptamine receptor 1E | 1954-03-26 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Bausch Health · 1 drug in Pre-Op Apprehension
- Generic (originally Rhône-Poulenc/Sanofi) · 1 drug in Pre-Op Apprehension
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Pre-Op Apprehension:
- Pre-Op Apprehension treatment updates — RSS
- Pre-Op Apprehension treatment updates — Atom
- Pre-Op Apprehension treatment updates — JSON
Cite this brief
Drug Landscape (2026). Pre-Op Apprehension — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pre-op-apprehension. Accessed 2026-06-10.
Related
- Pre-Op Apprehension full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing